2023-10-012024-09-302024-09-30false10383691GDK MEDI UK LTD2025-06-20falseiso4217:GBPxbrli:pure103836912023-10-01103836912024-09-30103836912023-10-012024-09-30103836912022-10-01103836912023-09-30103836912022-10-012023-09-3010383691bus:SmallEntities2023-10-012024-09-3010383691bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3010383691bus:AbridgedAccounts2023-10-012024-09-3010383691bus:PrivateLimitedCompanyLtd2023-10-012024-09-3010383691core:WithinOneYear2024-09-3010383691core:AfterOneYear2024-09-3010383691core:WithinOneYear2023-09-3010383691core:AfterOneYear2023-09-3010383691core:ShareCapital2024-09-3010383691core:SharePremium2024-09-3010383691core:RevaluationReserve2024-09-3010383691core:OtherReservesSubtotal2024-09-3010383691core:RetainedEarningsAccumulatedLosses2024-09-3010383691core:ShareCapital2023-09-3010383691core:SharePremium2023-09-3010383691core:RevaluationReserve2023-09-3010383691core:OtherReservesSubtotal2023-09-3010383691core:RetainedEarningsAccumulatedLosses2023-09-3010383691core:LandBuildings2024-09-3010383691core:PlantMachinery2024-09-3010383691core:Vehicles2024-09-3010383691core:FurnitureFittings2024-09-3010383691core:OfficeEquipment2024-09-3010383691core:NetGoodwill2024-09-3010383691core:IntangibleAssetsOtherThanGoodwill2024-09-3010383691core:ListedExchangeTraded2024-09-3010383691core:UnlistedNon-exchangeTraded2024-09-3010383691core:LandBuildings2023-09-3010383691core:PlantMachinery2023-09-3010383691core:Vehicles2023-09-3010383691core:FurnitureFittings2023-09-3010383691core:OfficeEquipment2023-09-3010383691core:NetGoodwill2023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-09-3010383691core:ListedExchangeTraded2023-09-3010383691core:UnlistedNon-exchangeTraded2023-09-3010383691core:LandBuildings2023-10-012024-09-3010383691core:PlantMachinery2023-10-012024-09-3010383691core:Vehicles2023-10-012024-09-3010383691core:FurnitureFittings2023-10-012024-09-3010383691core:OfficeEquipment2023-10-012024-09-3010383691core:NetGoodwill2023-10-012024-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3010383691core:ListedExchangeTraded2023-10-012024-09-3010383691core:UnlistedNon-exchangeTraded2023-10-012024-09-3010383691core:MoreThanFiveYears2023-10-012024-09-3010383691core:Non-currentFinancialInstruments2024-09-3010383691core:Non-currentFinancialInstruments2023-09-3010383691dpl:CostSales2023-10-012024-09-3010383691dpl:DistributionCosts2023-10-012024-09-3010383691core:LandBuildings2023-10-012024-09-3010383691core:PlantMachinery2023-10-012024-09-3010383691core:Vehicles2023-10-012024-09-3010383691core:FurnitureFittings2023-10-012024-09-3010383691core:OfficeEquipment2023-10-012024-09-3010383691dpl:AdministrativeExpenses2023-10-012024-09-3010383691core:NetGoodwill2023-10-012024-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3010383691dpl:GroupUndertakings2023-10-012024-09-3010383691dpl:ParticipatingInterests2023-10-012024-09-3010383691dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3010383691core:ListedExchangeTraded2023-10-012024-09-3010383691dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3010383691core:UnlistedNon-exchangeTraded2023-10-012024-09-3010383691dpl:CostSales2022-10-012023-09-3010383691dpl:DistributionCosts2022-10-012023-09-3010383691core:LandBuildings2022-10-012023-09-3010383691core:PlantMachinery2022-10-012023-09-3010383691core:Vehicles2022-10-012023-09-3010383691core:FurnitureFittings2022-10-012023-09-3010383691core:OfficeEquipment2022-10-012023-09-3010383691dpl:AdministrativeExpenses2022-10-012023-09-3010383691core:NetGoodwill2022-10-012023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3010383691dpl:GroupUndertakings2022-10-012023-09-3010383691dpl:ParticipatingInterests2022-10-012023-09-3010383691dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3010383691core:ListedExchangeTraded2022-10-012023-09-3010383691dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3010383691core:UnlistedNon-exchangeTraded2022-10-012023-09-3010383691core:NetGoodwill2024-09-3010383691core:IntangibleAssetsOtherThanGoodwill2024-09-3010383691core:LandBuildings2024-09-3010383691core:PlantMachinery2024-09-3010383691core:Vehicles2024-09-3010383691core:FurnitureFittings2024-09-3010383691core:OfficeEquipment2024-09-3010383691core:AfterOneYear2024-09-3010383691core:WithinOneYear2024-09-3010383691core:ListedExchangeTraded2024-09-3010383691core:UnlistedNon-exchangeTraded2024-09-3010383691core:ShareCapital2024-09-3010383691core:SharePremium2024-09-3010383691core:RevaluationReserve2024-09-3010383691core:OtherReservesSubtotal2024-09-3010383691core:RetainedEarningsAccumulatedLosses2024-09-3010383691core:NetGoodwill2023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-09-3010383691core:LandBuildings2023-09-3010383691core:PlantMachinery2023-09-3010383691core:Vehicles2023-09-3010383691core:FurnitureFittings2023-09-3010383691core:OfficeEquipment2023-09-3010383691core:AfterOneYear2023-09-3010383691core:WithinOneYear2023-09-3010383691core:ListedExchangeTraded2023-09-3010383691core:UnlistedNon-exchangeTraded2023-09-3010383691core:ShareCapital2023-09-3010383691core:SharePremium2023-09-3010383691core:RevaluationReserve2023-09-3010383691core:OtherReservesSubtotal2023-09-3010383691core:RetainedEarningsAccumulatedLosses2023-09-3010383691core:NetGoodwill2022-10-0110383691core:IntangibleAssetsOtherThanGoodwill2022-10-0110383691core:LandBuildings2022-10-0110383691core:PlantMachinery2022-10-0110383691core:Vehicles2022-10-0110383691core:FurnitureFittings2022-10-0110383691core:OfficeEquipment2022-10-0110383691core:AfterOneYear2022-10-0110383691core:WithinOneYear2022-10-0110383691core:ListedExchangeTraded2022-10-0110383691core:UnlistedNon-exchangeTraded2022-10-0110383691core:ShareCapital2022-10-0110383691core:SharePremium2022-10-0110383691core:RevaluationReserve2022-10-0110383691core:OtherReservesSubtotal2022-10-0110383691core:RetainedEarningsAccumulatedLosses2022-10-0110383691core:AfterOneYear2023-10-012024-09-3010383691core:WithinOneYear2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3010383691bus:Director12023-10-012024-09-3010383691bus:Director22023-10-012024-09-3010383691bus:Director32023-10-012024-09-30

GDK MEDI UK LTD

Registered Number
10383691
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2024

GDK MEDI UK LTD
Company Information
for the year from 1 October 2023 to 30 September 2024

Directors

HUANG, Anli, Ms.
HUANG, Xiaochun
YU, Qian

Registered Address

C/O Umc Accountants
314 Carshalton Road
Carshalton
SM5 3QB

Registered Number

10383691 (England and Wales)
GDK MEDI UK LTD
Balance Sheet as at
30 September 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,344227
1,344227
Current assets
Debtors137-
Cash at bank and on hand172,10495,747
172,24195,747
Creditors amounts falling due within one year(148,122)(78,208)
Net current assets (liabilities)24,11917,539
Total assets less current liabilities25,46317,766
Creditors amounts falling due after one year(10,000)-
Net assets15,46317,766
Capital and reserves
Called up share capital1,0001,000
Profit and loss account14,46316,766
Shareholders' funds15,46317,766
The financial statements were approved and authorised for issue by the Board of Directors on 20 June 2025, and are signed on its behalf by:
HUANG, Xiaochun
Director
Registered Company No. 10383691
GDK MEDI UK LTD
Notes to the Financial Statements
for the year ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year32
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 October 231,500
Additions1,310
At 30 September 242,810
Depreciation and impairment
At 01 October 231,273
Charge for year193
At 30 September 241,466
Net book value
At 30 September 241,344
At 30 September 23227
4.Related party transactions
Transactions with directors mainly arose business expenses paid on behalf of the company. The company was under the control of Ms. X Huang throughout the current and previous financial years, Ms. Huang is the managing directors and majority shareholding of the company. No transactions with related parties were undertaken such as are required to be disclosed under FRS 102 Section 1A.